ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

POLX Polarean Imaging Plc

3.90
0.00 (0.00%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.90 3.80 4.00 3.90 3.90 3.90 295,776 08:00:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 1.03M -13.91M -0.0644 -0.61 8.42M
Polarean Imaging Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker POLX. The last closing price for Polarean Imaging was 3.90p. Over the last year, Polarean Imaging shares have traded in a share price range of 3.72p to 32.25p.

Polarean Imaging currently has 215,848,593 shares in issue. The market capitalisation of Polarean Imaging is £8.42 million. Polarean Imaging has a price to earnings ratio (PE ratio) of -0.61.

Polarean Imaging Share Discussion Threads

Showing 151 to 173 of 6500 messages
Chat Pages: Latest  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
28/11/2019
16:29
Sometime between now and mid Jan. Likely first couple weeks of jan. What’s BTFD?
rhatton
28/11/2019
15:41
When are results expected? Worthy of BTFD?
cooltools
28/11/2019
15:17
Not exactly great price action here in the lead up to results.
rhatton
15/11/2019
14:57
This will recover eventually, comercial business model is very good. Tech is phenomenal and we have a board that's interests are aligned with shareholders, disappointed by the Fda delay but hey what can you do
superstockman
14/11/2019
16:36
bad start on this stock for me delay to FDA approval etc. quickly down 25% in the blink of any eye!!!!!!
finkie
09/11/2019
14:11
The company has options to generate cash next year and say a raise will not be required. Don't forget they can sell machines at $500k each c50% gross margins for research purposes and there are I believe other ways to generate cash before FDA approval and very large revenues kick in.

Also burn rate will be much lower after submission.

loglorry1
08/11/2019
14:11
Inverview out on Vox, sound's like a sensible approach to request pre nda meeting to dot the i's and cross the t's given current fda trend. Process could take much quicker if fda responses are timely.
aimsurfer
08/11/2019
10:00
Agreed that there is value in the company. Just annoyed that timelines have slipped.
mcfly79
08/11/2019
07:42
Wow over 22 million options and warrants outstanding on top of 114 million shares in issue on top of more confetti required next year
hamidahamida
07/11/2019
22:55
They had US$1.28m cash on 30 June and raised another £2m in July. Even if they do need to raise again it won't be until second half next year and until then lots of value to be added. What's the harm with them raising another £2m at some point next year?Over $50m spent on research, key patents, successful phase III trial done, commercialisation planned. How much do you think a company at that stage of development is worth?
aimsurfer
07/11/2019
16:10
Bit of a slip on timelines. I was hoping they would be on VOX today.

Readout will now be mid January and NDA submission by end of Q2 2020. FDA then have up to 12 months to review. So may not have commercial orders until mid 2021. Based on that timeline they will need a fundraise before commercial launch.

mcfly79
07/11/2019
14:42
8 months before they might get the approval long wait Big worry here now is Placing
hamidahamida
07/11/2019
08:32
Eye's on the prize. Those who wanted sales tomorrow have no clue on the potential here nor the value and interest each milestone brings to the company. I hope for gradual rise over coming weeks and months. Trial results is a major milestones, and industry interest should follow. Commercialisation plans already started. Would expect collaboration agreements with majors and potentially news from EMEA and Asia. If you want to see potential here, Blue Earth Diagnostics sold for $450m.
aimsurfer
07/11/2019
07:35
Another 8 months wait before they might get the FDA approval
hamidahamida
01/11/2019
11:51
Trial completion any day now, results and FDA submission before year end. Few collaborations, FDA approval and initial revenue from scans in late 2020 would do me nicely :)
aimsurfer
01/11/2019
10:24
new investor to this company here can someone briefly update me on key timelines here, many thanks
finkie
30/10/2019
09:36
I think trials are scheduled to complete end of the monthSo news any time?
mrs robinson
28/10/2019
22:22
Two large traders reported late, not sure if it was a transfer of stock. Interestingly I could sell a decent chunk all week at close the live price, there must be some buyers in the background. Anyway very close now to trial completion.
aimsurfer
28/10/2019
16:31
Chunky trade just gone through!
rhatton
22/10/2019
16:58
Phase 3 success and few collaborations in the bag I hope to see us around 50p, this is before official FDA approval. Bigger gains once commercial rollout begins?
aimsurfer
22/10/2019
16:09
What are the projections around here if things are successful with phase 3?
rhatton
16/10/2019
15:18
Two patients left, one in each trial. Will complete in October and results still expected to be announced this year.Expecting good Xmas here :)
aimsurfer
16/10/2019
13:53
New podcast Listen to "Richard Hullihen CEO of Polarean Imagining and John Meyer on Resource Stocks" https://www.voxmarkets.co.uk?mediaAssetId=5da70426052336001724ec40 @VoxMarkets
hamidahamida
Chat Pages: Latest  8  7  6  5  4  3  2  1

Your Recent History

Delayed Upgrade Clock